Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: Reduction by a selective serotonin reuptake inhibitor
暂无分享,去创建一个
G. Jennings | M. Esler | T. Dawood | M. Alvarenga | D. Barton | D. Kaye | G. Lambert | E. Lambert | Ling Guo | C. Pier | Celia Brenchley | V. Kalff | M. Kelly | D. Haikerwal | J. Hastings | G. Wiesner | F. Socratous | J. Richards
[1] Thomas H. Ollendick,et al. Concurrent Validity and Informant Agreement of the ADHD Module of the Anxiety Disorders Interview Schedule for DSM-IV , 2007 .
[2] J. Mann,et al. Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid levels in women with comorbid depression and panic disorder. , 2006, The international journal of neuropsychopharmacology.
[3] M. Esler,et al. Psychophysiological Mechanisms in Panic Disorder: A Correlative Analysis of Noradrenaline Spillover, Neuronal Noradrenaline Reuptake, Power Spectral Analysis of Heart Rate Variability, and Psychological Variables , 2006, Psychosomatic medicine.
[4] E. Maron,et al. Associations between serotonin-related gene polymorphisms and panic disorder. , 2005, The international journal of neuropsychopharmacology.
[5] E. Rabiner,et al. P3.044 Alttered 5HT1A binding in panic disorderdemonstrated by positron emission tomography , 2004, European Neuropsychopharmacology.
[6] Joseph E. LeDoux,et al. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine , 2004, Biological Psychiatry.
[7] Peter Herscovitch,et al. Reduced Serotonin Type 1A Receptor Binding in Panic Disorder , 2004, The Journal of Neuroscience.
[8] M. Esler,et al. Effect of sunlight and season on serotonin turnover in the brain , 2002, The Lancet.
[9] M. Esler,et al. Norepinephrine Turnover Is Increased in Suprabulbar Subcortical Brain Regions and Is Related to Whole-Body Sympathetic Activity in Human Heart Failure , 2002, Circulation.
[10] M. Toth,et al. The 5-HT(1A) receptor knockout mouse and anxiety. , 2001, Behavioural pharmacology.
[11] M K Shear,et al. Reliability and validity of the Panic Disorder Severity Scale: replication and extension. , 2001, Journal of psychiatric research.
[12] Trevor R. Norman. Experimental and Clinical Pharmacology: The new antidepressants - mechanisms of action , 1999 .
[13] R. Hen,et al. Altered Emotional States in Knockout Mice Lacking 5-HT1A or 5-HT1B Receptors , 1999, Neuropsychopharmacology.
[14] J. Herman,et al. Excitatory Influence of the Locus Coeruleus in Hypothalamic‐Pituitary‐Adrenocortical Axis Responses to Stress , 1999, Journal of neuroendocrinology.
[15] D. Murphy,et al. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. , 1999, American journal of medical genetics.
[16] D. Kennaway,et al. Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms , 1998, Brain Research.
[17] G. Jennings,et al. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. , 1998, Archives of general psychiatry.
[18] G. Bagdy. Serotonin, Anxiety, and Stress Hormones: Focus on 5‐HT Receptor Subtypes, Species and Gender Differences a , 1998, Annals of the New York Academy of Sciences.
[19] B. Wallin,et al. Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity. , 1998, Acta physiologica Scandinavica.
[20] F. Graeff,et al. Dual role of 5-HT in defense and anxiety , 1997, Neuroscience & Biobehavioral Reviews.
[21] M K Shear,et al. Multicenter collaborative panic disorder severity scale. , 1997, The American journal of psychiatry.
[22] N. Singewald,et al. Release of Serotonin in the Rat Locus Coeruleus: Effects of Cardiovascular, Stressful and Noxious Stimuli , 1997, The European journal of neuroscience.
[23] K. Lesch,et al. Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.
[24] B. Jacobs,et al. A microdialysis examination of serotonin release in the rat forebrain induced by behavioral/environmental manipulations , 1996, Brain Research.
[25] P Riederer,et al. Allelic Variation of Human Serotonin Transporter Gene Expression , 1996, Journal of neurochemistry.
[26] F. Graeff,et al. Role of 5-HT in stress, anxiety, and depression , 1996, Pharmacology Biochemistry and Behavior.
[27] G. Jennings,et al. Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation. , 1995, Journal of the autonomic nervous system.
[28] G. Jennings,et al. Regional 5-hydroxyindoleacetic acid production in humans. , 1995, Life sciences.
[29] I. Lucki,et al. Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid , 1995, Brain Research.
[30] David Julius,et al. Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors , 1995, Nature.
[31] R. Spitzer. Dsm-IV Casebook: A Learning Companion to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition , 1994 .
[32] G. Jennings,et al. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension , 1993, Journal of hypertension.
[33] Y. Oomura,et al. In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: Significant enhancement by immobilization stress in rats , 1992, Brain Research Bulletin.
[34] I. Meredith,et al. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. , 1991, The New England journal of medicine.
[35] I. Törk. Anatomy of the Serotonergic System a , 1990, Annals of the New York Academy of Sciences.
[36] W. Goodman,et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.
[37] G Kishi,et al. Reliability and Validity , 1999 .
[38] P. Korner,et al. Measurement of total and organ-specific norepinephrine kinetics in humans. , 1984, The American journal of physiology.
[39] D E Redmond,et al. Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety. , 1979, Life sciences.
[40] N. M. Greene,et al. 3-Methoxy-4-hydroxyphenethyleneglycol production by human brain in vivo. , 1979, Science.
[41] J. Maas,et al. A DIRECT METHOD FOR DETERMINING DOPAMINE SYNTHESIS AND OUTPUT OF DOPAMINE METABOLITES FROM BRAIN IN AWAKE ANIMALS , 1979, Journal of neurochemistry.
[42] Roger Kurlan,et al. Pressure sores , 1989 .
[43] T. Brown,et al. The Anxiety Disorders Interview Schedule for DSM-IV (ADIS-IV). , 2004 .
[44] G. Jennings,et al. Human obesity is associated with a chronic elevation in brain 5-hydroxytryptamine turnover. , 1999, Clinical science.
[45] G. Jennings,et al. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity. , 1991, Life sciences.